ARE THERE ANY SPECIFIC MORPHOPATHOLOGICAL FEATURES IN EMERGENCY COLON CANCER SURGERY?

  • Andrei Nicolaescu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Sandu Ramboiu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Daniela Marinescu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Ana-Maria Pătrașcu Department of Hematology, University of Medicine and Pharmacy of Craiova, Romania
  • Sarmis Săndulescu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Dan Cârțu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Ștefan Pătrașcu Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
  • Valeriu Șurlin Department of General Surgery, University of Medicine and Pharmacy of Craiova, Romania
Keywords: emergency surgery, colon cancer, tumor grade, tumor type

Abstract

The increased incidence of colon cancer patients requiring emergency surgery should raise more interest in its complete morphopathological characterization. We performed a retrospective analysis of all colon cancer patients admitted through the emergency setting and operated in our Institution during the last 5 years. Special emphasis was put on the morphological features of the cases, such as histopathologic type, grading, TNM staging, tumoral inflammatory infiltrate, perineural and vascular invasion.We identified 104 patients that underwent radical colon cancer surgery in the emergency setting between 2017 and 2021. Most cases were located on the sigmoid colon and were diagnosed as either locally advanced (92%) or metastatic disease (19%). Vascular invasion was identified in 29% of specimens, while perineural invasion was found in 38% of cases. Colon cancer patients undergoing emergency radical surgery display independent risk factors for the postoperative and the overall oncologic outcomes, such as comedo-necrosis, high lymph node involvement, locally advanced or metastatic disease, and perineural and vascular invasion.

 

References

[1] R. Bonetti, V. Barresi, S. Bettelli, et al., “Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known”, Diagn Pathol, vol. 11, pp. 31, 2016.
[2] R. Siegel, E. Ward, O. Brawley, et al., “Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths”, CA Cancer J Clin, vol. 61, pp. 212-236, 2011.
[3] J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”, Int J Cancer, vol. 127, pp. 2893–2917, 2010.
[4] H. J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, B. Nordlinger, C. J. van de Velde, J. Balmana, J. Regula, et al., “ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making”, Ann. Oncol, vol. 23, pp. 2479–2516, 2012.
[5] E. Van Cutsem, A. Cervantes, B. Nordlinger, D. Arnold, “Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”, Ann. Oncol., vol. 25, pp. 31–39, 2014.
[6] R. Adam, A. De Gramont, J. Figueras, A. Guthrie, N. Kokudo, F. Kunstlinger, E. Loyer, G. Poston, P. Rougier, L. Rubbia-Brandt, et al., “The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus”, Oncologist, vol. 17, pp. 1225–1239, 2012.
[7] V. Barresi, L. Reggiani Bonetti, A. Ieni, F. Domati, G. Tuccari. “Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma”, Hum Pathol, vol. 46, pp.1722–9, 2015.
[8] G. Gasparini, R. Longo, F. Torino, D. Gattuso, A. Morabito, G. Toffoli, “Is tailored therapy feasible in oncology?”, Crit Rev Oncol Hematol., vol. 57, pp. 79-101, 2006
[9] M. B. Amin, S. B. Edge, F. L. Greene, et al, “eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer”, 2017.
[10] K. Klintrup, J.M. Mäkinen, S. Kauppila, P. O. Väre, J. Melkko, H. Tuominen, K. Tuppurainen, J. Mäkelä, T. J. Karttunen, M. J. Mäkinen, “Inflammation and prognosis in colorectal cancer”, Eur J Cancer, vol. 41, pp. 2645-54, 2005.
[11] S. R. Hamilton, F. T. Bosman, P. Boffetta, et al., “Carcinoma of the colon and rectum”, WHO Classification of Tumours of the Digestive System, eds. Lyon: IARC Press, pp. 134-46, 2010.
[12] M. Fleming, S. Ravula, S. F. Tatishchev, H. L. Wang, “Colorectal carcinoma: Pathologic aspects”, J Gastrointest Oncol., vol. 3, pp. 153-173, 2012.
[13] G. Lanza, R. Gafà, M. Matteuzzi, A. Santini, “Medullary type poorly differentiated adenocarcinoma of the large bowel: Distinct clinicopathological entity characterized by microsatellite instability and improved survival”, J. Clin. Oncol., vol. 17, pp. 2429–2438, 1999.
[14] P. Thirunavukarasu, M. Sathaiah, S. Singla, S. Sukumar, A. Karunamurthy, K. D. Pragatheeshwar, K. K. Lee, H. Zeh, K.M. Kane, D. L. Bartlett, “Medullary carcinoma of the large intestine: A population based analysis”, Int. J. Oncol., vol. 37, pp. 901–907, 2010.
[15] M. J. Makinen, “Colorectal serrated adenocarcinoma”, Histopathology, vol. 50, pp. 131–150, 2007.
[16] T. Fujii, T. Sutoh, H. Morita, R. Yajima, S. Yamaguchi, S. Tsutsumi, T. Asao, H. Kuwano, “Vascular invasion, but not lymphatic invasion, of the primary tumor is a strong prognostic factor in patients with colorectal cancer”, Anticancer Res., vol. 34, pp. 3147-51, 2014.
[17] C. Liebig, G. Ayala, J. Wilks, et al., “Perineural invasion is an independent predictor of outcome in colorectal cancer”, J Clin Oncol., vol. 27, pp. 5131-37, 2009.
[18] J. Tu, Z. Yao, W. Wu, J. Ju, Y. Xu, Y. Liu, “Perineural Invasion Is a Strong Prognostic Factor but Not a Predictive Factor of Response to Adjuvant Chemotherapy in Node-Negative Colon Cancer”, Front Oncol., vol. 11, pp. 6631-54, 2021
[19] D. Kohoutova, J. Pejchal, J. Bures, “Mitotic and apoptotic activity in colorectal neoplasia”, BMC Gastroenterol, vol. 18, pp. 65, 2018.
[20] F. A. Sinicrope, J. Hart, H. A. Hsu, M. Lemoine, F. Michelassi, L. C. Stephens, “Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas”, Clin Cancer Res., vol. 5, pp. 1793-804, 1999.
Published
2021-07-09
How to Cite
[1]
A. Nicolaescu, “ARE THERE ANY SPECIFIC MORPHOPATHOLOGICAL FEATURES IN EMERGENCY COLON CANCER SURGERY?”, JSS, vol. 8, no. 2, Jul. 2021.